Transcriptional program induced by factor VIIa-tissue factor, PAR1 and PAR2 in MDA-MB-231 cells

Journal of Thrombosis and Haemostasis

Volumn 5, Issue 8, 2007, Pages 1588-1597

  Albrektsen, T ^a   Sorensen B B ^a   Hjorto G M ^a   Fleckner, J ^a   Rao, L V M ^b   Petersen, Lars C ^a  

^a NOVO NORDISK A S   (Denmark)

^b UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

Author keywords

Factor VIIa; Gene transcription; Protease activated; Protease activated receptor 2; Receptor 1; Signaling

Indexed keywords

BLOOD CLOTTING FACTOR 7A; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 2; THROMBIN; THROMBOPLASTIN;

ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CARCINOGENESIS; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; GLIOBLASTOMA; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; UNINDEXED SEQUENCE; WOUND HEALING;

BINDING SITES; CELL LINE, TUMOR; FACTOR VIIA; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PEPTIDES; RECEPTOR, PAR-1; RECEPTOR, PAR-2; SIGNAL TRANSDUCTION; THROMBOPLASTIN; TRANSCRIPTION, GENETIC;

EID: 34447617537     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2007.02603.x     Document Type: Article

References (41)

1. Osterud B, Bjorklid E. Sources of tissue factor. Semin Thromb Hemost 2006; 32: 11-23.
2. Wilcox JN, Smith KM, Schwartz SM, Gordon D. Locallization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA 1989; 86: 2839-43.
3. Mackman N. Role of tissue factor in hemostasis, thrombosis, and vascular development. Arterioscler Thromb Vasc Biol 2004; 24: 1015-22.
4. Taubman MB, Fallon JT, Schecter AD, Giesen P, Mendlowitz M, Fyfe BS, Marmur JD, Nemerson Y. Tissue factor in the pathogenesis of atherosclerosis. Thromb Haemost 1997; 78: 200-4.
5. Belting M, Ahamed J, Ruf W. Signaling of the tissue factor coagulation pathway in angiogenesis and cancer. Arterioscler Thromb Vasc Biol 2005; 25: 1545-50.
6. Rao LVM, Pendurthi UR. Tissue factor-factor VIIa signaling. Arterioscler Thromb Vasc Biol 2005; 25: 47-56.
7. Callander NS, Varki N, Rao LVM. Immunohistochemical identification of tissue factor in solid tumors. Cancer 1992; 70: 11941201.
8. Sorensen BB, Freskgard PO, Nielsen LS, Rao LVM, Ezban M, Petersen LC. Factor VIIa-induced p44/42 mitogen-activated protein kinase activation requires the proteolytic activity of factor VIIa and is independent of the tissue factor cytoplasmic domain. J Biol Chem 1999; 274: 21349-54.
9. Camerer E, Huang W, Coughlin SR. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. Proc Natl Acad Sci USA 2000; 97: 5255-60.
10. Hjortoe GM, Petersen LC, Albrektsen T, Sorensen BB, Norby PL, Mandal SK, Pendurthi UR, Rao LVM. Tissue factor-factor VIIa-specific up-regulation of IL-8 expression in MDA-MB-231 cells is mediated by PAR-2 and results in increased cell migration. Blood 2004; 103: 3029-37.
11. Thim L, Bjoern S, Christensen M, Nicolaisen EM, Lund-Hansen T, Pedersen AH, Hedner U. Amino acid sequence and posttranslational modifications of human factor VIIa from plasma and transfected baby hamster kidney cells. Biochemistry 1988; 27: 7785-93.
12. Sorensen BB, Persson E, Freskgard PO, Kjalke M, Ezban M, Williams T, Rao LVM. Incorporation of an active-site inhibitor in factor viia alters the affinity for tissue factor. J Biol Chem 1997; 272: 11863-8.
13. Edwards D. Non-linear normalization and background correction in one-channel cDNA microarray studies. Bioinformatics 2003; 19: 825-33.
14. Bolstad BM, Irizarry RA, Astrand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003; 19: 185-93.
15. Gibson UEM, Heid CA, Williams PM. A novel method for real time quantitative RT-PCR. Genome Res 1996; 6: 995-1001.
16. Heid CA, Stevens J, Livak KJ, Williams PM. Real-time quantitative pcr. Genome Res 1996; 6: 986-94.
17. Camerer E, Kataoka H, Kahn M, Lease K, Coughlin SR. Genetic evidence that protease-activated receptors mediate factor Xa signaling in endothelial cells. J Biol Chem 2002; 277: 16081-7.
18. Kawabata A, Kuroda R, Nakaya Y, Kawai K, Nishikawa H, Kawao N. Factor Xa-evoked relaxation in rat aorta: Involvement of PAR- 2. Biochem Biophys Res Commun 2001; 282: 432-5.
19. Pendurthi UR, Allen KE, Ezban M, Rao LVM. Factor VIIa and thrombin induce the expression of Cyr61 and connective tissue growth factor, extracellular matrix signaling proteins that could act as possible downstream mediators in factor VIIa center dot tissue factor-induced signal transduction. J Biol Chem 2000; 275: 14632-41.
20. Morris DR, Ding Y, Ricks TK, Gullapalli A, Wolfe BL, Trejo J. Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells. Cancer Res 2006; 66: 307-14.
21. Riewald M, Ruf W. Protease-activated receptor-1 signaling by activated protein C in cytokine-perturbed endothelial cells is distinct from thrombin signaling. J Biol Chem 2005; 280: 19808-14.
22. Siegbahn A, Johnell M, Rorsman C, Ezban M, Heldin CH, Ronnstrand L. Binding of factor VIIa to tissue factor on human fibroblasts leads to activation of phospholipase C and enhanced PDGF-BB- stimulated chemotaxis. Blood 2000; 96: 3452-8.
23. Sorensen BB, Rao LVM, Tornehave D, Gammeltoft S, Petersen LC. Antiapoptotic effect of coagulation factor VIIa. Blood 2003; 102: 1708-15.
24. Versteeg HH, Spek CA, Richel DJ, Peppelenbosch MP. Coagulation factors VIIa and Xa inhibit apoptosis and anoikis. Oncogene 2004; 23: 410-7.
25. Ahamed J, Ruf W. Protease-activated receptor 2-dependent phosphorylation of the tissue factor cytoplasmic domain. J Biol Chem 2004; 279: 23038-44.
26. Belting M, Dorrell MI, Sandgren S, Aguilar E, Ahamed J, Dorfleutner A, Carmeliet P, Mueller BM, Friedlander M, Ruf W. Regulation of angiogenesis by tissue factor cytoplasmic domain signaling. Nat Med 2004; 10: 502-9.
27. Dorfleutner A, Hintermann E, Tarui T, Takada Y, Ruf W. Cross-talk of integrin alpha 3 beta 1 and tissue factor in cell migration. Mol Biol Cell 2004; 15: 4416-25.
28. Belperio JA, Keane MP, Arenberg DA, Addison CL, Ehlert JE, Burdick MD, Strieter RM. CXC chemokines in angiogenesis. J Leukoc Biol 2000; 68: 1-8.
29. Strieter RM, Belperio JA, Phillips RJ, Keane MP. CXC chemokines in angiogenesis of cancer. Semin Cancer Biol 2004; 14: 195-200.
30. Barreda DR, Hanington PC, Belosevic M. Regulation of myeloid development and function by colony stimulating factors. Dev Comp Immunol 2004; 28: 509-54.
31. Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 2004; 4: 71-8.
32. Bottazzi B, Vouretcraviari V, Bastone A, Degioia L, Matteucci C, Peri G, Spreafico F, Pausa M, Dettorre C, Gianazza E, Tagliabue A, Salmona M, Tedesco F, Introna M. Multimer formation and ligand recognition by the long pentraxin ptx3 - similarities and differences with the short pentraxins c-reactive protein and serum amyloid-p component. J Biol Chem 1997; 272: 32817-23.
33. Napoleone E, Di-Santo A, Bastone A, Peri G, Mantovani A, de-Gaetano G, Donati MB, Lorenzet R. Long pentraxin PTX3 upregulates tissue factor expression in human endothelial cells - A novel link between vascular inflammation and clotting activation. Arterioscler Thromb Vasc Biol 2002; 22: 782-7.
34. Rusnati M, Camozzi M, Moroni E, Bottazzi B, Peri G, Indraccolo S, Amadori A, Mantovani A, Presta M. Selective recognition of fibroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesis. Blood 2004; 104: 92-9.
35. Eubank TD, Galloway M, Montague CM, Waldman WJ, Marsh CB. M-CSF induces vascular endothelial growth factor production and angiogenic activity from human monocytes. J Immunol 2003; 171: 2637-43.
36. Lee J, Gray A, Yuan J, Luoh SM, Avraham H, Wood WI. Vascular endothelial growth factor-related protein - a ligand and specific activator of the tyrosine kinase receptor flt4. Proc Natl Acad Sci USA 1996; 93: 1988-92.
37. Enholm B, Jussila L, Karkkainen M, Alitalo K. Vascular endothelial growth factor-C: A growth factor for lymphatic and blood vascular endothelial cells. Trends Cardiovasc Med 1998; 8: 292-7.
38. Desbaillets I, Diserens AC, Detribolet N, Hamou MF, Vanmeir EG. Up-regulation of interleukin-8 by oxygen-deprived cells in glioblastoma suggests a role in leukocyte activation, chemotaxis, and angiogenesis. J Exp Med 1997; 186: 1201-12.
39. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, Dipietro LA, Elner VM, Elner SG, Strieter RM. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science (Washington DC)1992; 258: 1798-801.
40. Chen CC, Mo FE, Lau LF. The angiogenic factor Cyr61 activates a genetic program for wound healing in human skin fibroblasts. J Biol Chem 2001; 276: 47329-37.
41. Wang JF, Olson ME, Ball DK, Brigstock DR, Hart DA. Recombinant connective tissue growth factor modulates porcine skin fibroblast gene expression. Wound Repair Regen 2003; 11: 220-9.